Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

EU Pharma Strategy: Success depends on access to Generic, Biosimilar and Value Added Medicines

25 November 2020

Open

IGBA Launches First Global Biosimilars Week

16 November 2020

Open

European Health Union – first step to greater EU solidarity in health crisis situations

11 November 2020

Open

Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

9 November 2020

Open

Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

5 November 2020

Open

Open letter from Medicines for Europe Executive on the upcoming EU pharmaceutical strategy

20 October 2020

Open

Statement from the President: Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing

7 October 2020

Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’, […]

Read more

IGBA: Global Roadmap for Tailored Clinical Biosimilar Development: Instrumental for Sustainable Access to Biologics

24 September 2020

Open

Joint press statement of European Pharmaceutical industry associations

17 September 2020

Open

Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies

17 September 2020

Open

Subscribe to our newsletter